111In-DOTA-NCS-ST-peptide

¹¹¹In-DOTA-NCS-ST-peptide,¹¹¹In-DOTA-NCS-6-Ahx-Phe19-ST[1-19] is a promising compound for enhancing the precision of imaging and treatment in oncology. Its design allows for the effective targeting of tumors, and ongoing research explores its full potential in clinical applications. The ability to label peptides with 111In through stable chelation with DOTA and reactive NCS groups provides a fascinating avenue for the development of advanced radiopharmaceuticals, merging nuclear medicine with peptide-targeted therapy.

msds of 111In-DOTA-NCS-ST-peptide